Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R D Hull

Showing results (121-130 of 140) with videos related to

Pageof 14
Sort By:
Circulation|April 1, 1983
The diagnosis of acute, recurrent, deep-vein thrombosis: a diagnostic challengeR D Hull, C J Carter, R M Jay, et al.
Journal of Applied Toxicology : JAT|December 1, 1992
Pulmonary reactivity to vanadium pentoxide following subchronic inhalation exposure in a non-human primate animal modelE A Knecht, W J Moorman, J C Clark, et al.
Chest|December 1, 1985
Diagnostic value of ventilation-perfusion lung scanning in patients with suspected pulmonary embolismR D Hull, J Hirsh, C J Carter, et al.
Archives of Internal Medicine|February 10, 1997
Subcutaneous low-molecular-weight heparin vs warfarin for prophylaxis of deep vein thrombosis after hip or knee implantation. An economic perspectiveR D Hull, G E Raskob, G F Pineo, et al.
Archives of Internal Medicine|January 27, 2000
Low-molecular-weight heparin vs heparin in the treatment of patients with pulmonary embolism. American-Canadian Thrombosis Study GroupR D Hull, G E Raskob, R F Brant, et al.
JAMA|May 2, 1990
Effectiveness of intermittent pneumatic leg compression for preventing deep vein thrombosis after total hip replacementR D Hull, G E Raskob, M Gent, et al.
Archives of Internal Medicine|July 25, 2000
Low-molecular-weight heparin prophylaxis using dalteparin in close proximity to surgery vs warfarin in hip arthroplasty patients: a double-blind, randomized comparison. The North American Fragmin Trial InvestigatorsR D Hull, G F Pineo, C Francis, et al.
Archives of Internal Medicine|August 1, 1992
Optimal therapeutic level of heparin therapy in patients with venous thrombosisR D Hull, G E Raskob, D Rosenbloom, et al.
Archives of Internal Medicine|July 25, 2000
Low-molecular-weight heparin prophylaxis using dalteparin extended out-of-hospital vs in-hospital warfarin/out-of-hospital placebo in hip arthroplasty patients: a double-blind, randomized comparison. North American Fragmin Trial InvestigatorsR D Hull, G F Pineo, C Francis, et al.
Archives of Internal Medicine|February 10, 1997
Treatment of proximal vein thrombosis with subcutaneous low-molecular-weight heparin vs intravenous heparin. An economic perspectiveR D Hull, G E Raskob, D Rosenbloom, et al.
Pageof 14

Showing results (121-130 of 140) with videos related to

Sort By:
Pageof 14
Circulation|April 1, 1983
The diagnosis of acute, recurrent, deep-vein thrombosis: a diagnostic challengeR D Hull, C J Carter, R M Jay, et al.
Journal of Applied Toxicology : JAT|December 1, 1992
Pulmonary reactivity to vanadium pentoxide following subchronic inhalation exposure in a non-human primate animal modelE A Knecht, W J Moorman, J C Clark, et al.
Chest|December 1, 1985
Diagnostic value of ventilation-perfusion lung scanning in patients with suspected pulmonary embolismR D Hull, J Hirsh, C J Carter, et al.
Archives of Internal Medicine|February 10, 1997
Subcutaneous low-molecular-weight heparin vs warfarin for prophylaxis of deep vein thrombosis after hip or knee implantation. An economic perspectiveR D Hull, G E Raskob, G F Pineo, et al.
Archives of Internal Medicine|January 27, 2000
Low-molecular-weight heparin vs heparin in the treatment of patients with pulmonary embolism. American-Canadian Thrombosis Study GroupR D Hull, G E Raskob, R F Brant, et al.
JAMA|May 2, 1990
Effectiveness of intermittent pneumatic leg compression for preventing deep vein thrombosis after total hip replacementR D Hull, G E Raskob, M Gent, et al.
Archives of Internal Medicine|July 25, 2000
Low-molecular-weight heparin prophylaxis using dalteparin in close proximity to surgery vs warfarin in hip arthroplasty patients: a double-blind, randomized comparison. The North American Fragmin Trial InvestigatorsR D Hull, G F Pineo, C Francis, et al.
Archives of Internal Medicine|August 1, 1992
Optimal therapeutic level of heparin therapy in patients with venous thrombosisR D Hull, G E Raskob, D Rosenbloom, et al.
Archives of Internal Medicine|July 25, 2000
Low-molecular-weight heparin prophylaxis using dalteparin extended out-of-hospital vs in-hospital warfarin/out-of-hospital placebo in hip arthroplasty patients: a double-blind, randomized comparison. North American Fragmin Trial InvestigatorsR D Hull, G F Pineo, C Francis, et al.
Archives of Internal Medicine|February 10, 1997
Treatment of proximal vein thrombosis with subcutaneous low-molecular-weight heparin vs intravenous heparin. An economic perspectiveR D Hull, G E Raskob, D Rosenbloom, et al.
Pageof 14